- Home
- HYB vs CMPX Comparison
HYB vs CMPX Comparison
Compare HYB & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HYB
- CMPX
- Stock Information
- Founded
- HYB 1987
- CMPX 2014
- Country
- HYB United States
- CMPX United States
- Employees
- HYB N/A
- CMPX N/A
- Industry
- HYB Investment Managers
- CMPX Biotechnology: Pharmaceutical Preparations
- Sector
- HYB Finance
- CMPX Health Care
- Exchange
- HYB Nasdaq
- CMPX Nasdaq
- Market Cap
- HYB 194.0M
- CMPX 217.4M
- IPO Year
- HYB 1999
- CMPX N/A
- Fundamental
- Price
- HYB $8.25
- CMPX $1.54
- Analyst Decision
- HYB
- CMPX Strong Buy
- Analyst Count
- HYB 0
- CMPX 2
- Target Price
- HYB N/A
- CMPX $9.00
- AVG Volume (30 Days)
- HYB 39.6K
- CMPX 366.4K
- Earning Date
- HYB 01-01-0001
- CMPX 11-07-2024
- Dividend Yield
- HYB 6.67%
- CMPX N/A
- EPS Growth
- HYB N/A
- CMPX N/A
- EPS
- HYB N/A
- CMPX N/A
- Revenue
- HYB N/A
- CMPX $850,000.00
- Revenue This Year
- HYB N/A
- CMPX N/A
- Revenue Next Year
- HYB N/A
- CMPX $950.68
- P/E Ratio
- HYB N/A
- CMPX N/A
- Revenue Growth
- HYB N/A
- CMPX N/A
- 52 Week Low
- HYB $6.23
- CMPX $0.77
- 52 Week High
- HYB $7.41
- CMPX $2.34
- Technical
- Relative Strength Index (RSI)
- HYB 67.42
- CMPX 61.93
- Support Level
- HYB $8.25
- CMPX $1.42
- Resistance Level
- HYB $8.41
- CMPX $1.65
- Average True Range (ATR)
- HYB 0.08
- CMPX 0.13
- MACD
- HYB -0.02
- CMPX 0.01
- Stochastic Oscillator
- HYB 51.52
- CMPX 57.76
About HYB New America High Income Fund Inc. (The)
New America High Income Fund Inc is a diversified, closed‐end management investment company. Its investment objective is to provide high current income while seeking to preserve stockholder capital by investing in a diversified portfolio of high-yield fixed-income securities. The Fund has a leveraged capital structure. The fund invests in fixed-maturity corporate debt securities that are rated less than the investment grade. Its portfolio of investment consists of investments in different sectors such as energy, financial, cable operators, healthcare, and others.
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of three product candidates, CTX-009, CTX-471, and CTX-8371.